Impacts of competition and phenotypic plasticity on the viability of adaptive therapy.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Mathematical Biosciences

• Publication date

  2025-09-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.mbs.2025.109522PMID 40935079PMCID PMC12515544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding therapeutic tolerance through a mathematical model of drug-induced resistance

  2024cited by this paper
• A mathematical framework for comparison of intermittent versus continuous adaptive chemotherapy dosing in cancer

  2024influential reference
• Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer

  2024cited by this paper
• Optimal dosing of anti-cancer treatment under drug-induced plasticity

  2024cited by this paper
• Optimal phenotypic adaptation in fluctuating environments

  2023cited by this paper
• Understanding and leveraging phenotypic plasticity during metastasis formation

  2023cited by this paper
• A resource-based mechanistic framework for castration-resistant prostate cancer (CRPC)

  2023cited by this paper
• Cell facilitation promotes growth and survival under drug pressure in breast cancer

  2023cited by this paper
• Evolution-based mathematical models significantly prolong response to abiraterone in metastatic castrate-resistant prostate cancer and identify strategies to further improve outcomes

  2022cited by this paper
• Find the path of least resistance: Adaptive therapy to delay treatment failure and improve outcomes.

  2022cited by this paper
• Estrogen as an Essential Resource and the Coexistence of ER+ and ER– Cancer Cells

  2021cited by this paper
• Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing

  2021cited by this paper
• Adaptive Therapy for Metastatic Melanoma: Predictions from Patient Calibrated Mathematical Models

  2021cited by this paper
• Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells

  2021cited by this paper
• Transition Therapy: Tackling the Ecology of Tumor Phenotypic Plasticity

  2020cited by this paper
• Spatial structure impacts adaptive therapy by shaping intra-tumoral competition

  2020cited by this paper
• Understanding the role of phenotypic switching in cancer drug resistance.

  2020cited by this paper
• Turnover Modulates the Need for a Cost of Resistance in Adaptive Therapy

  2020cited by this paper
• Cancer therapy: Attempt cure or manage drug resistance?

  2020cited by this paper
• Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation

  2019cited by this paper
• SciPy 1.0: fundamental algorithms for scientific computing in Python

  2019cited by this paper
• Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas

  2019cited by this paper
• Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution

  2019cited by this paper
• Towards Multidrug Adaptive Therapy

  2018cited by this paper
• Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer.

  2018cited by this paper
• GenSSI 2.0: multi-experiment structural identifiability analysis of SBML models

  2017cited by this paper
• Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model.

  2017cited by this paper
• Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer

  2017cited by this paper
• How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient

  2017cited by this paper
• Spatial competition constrains resistance to targeted cancer therapy

  2017cited by this paper
• Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer

  2016cited by this paper
• Intra‐tumour heterogeneity – going beyond genetics

  2016cited by this paper
• Tumour Cell Heterogeneity

  2016cited by this paper
• Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer

  2015cited by this paper
• Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.

  2015cited by this paper
• Cellular heterogeneity and molecular evolution in cancer.

  2013cited by this paper
• An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)

  2013cited by this paper
• TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma

  2012cited by this paper
• EMT in carcinoma progression and dissemination: Facts, unanswered questions, and clinical considerations

  2012cited by this paper
• Testosterone in prostate cancer: the Bethesda consensus

  2012cited by this paper
• Androgen-responsive and nonresponsive prostate cancer cells present a distinct glycolytic metabolism profile.

  2012cited by this paper
• Cancer chemotherapy: a critical analysis of its 60 years of history.

  2012cited by this paper
• The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis

  2011cited by this paper
• A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.

  2010cited by this paper
• ggplot2: Elegant Graphics for Data Analysis

  2010influential reference
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• Adaptive therapy.

  2009cited by this paper
• Derivation of embryonic stem-cell lines from human blastocysts.

  2004cited by this paper
• The effect of age, race, tumor size, tumor grade, and disease stage on invasive ductal breast cancer survival in the U.S. SEER database

  2004cited by this paper
• Spatial Heterogeneity, Source‐Sink Dynamics, and the Local Coexistence of Competing Species

  2001cited by this paper
• The Exponential-Gompertzian Tumor Growth Model: Data from Six Tumor Cell Lines in Vitro and in Vivo. Estimate of the Transition point from Exponential to Gompertzian Growth and Potential Cinical Implications

  1991cited by this paper
• Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

  1989cited by this paper
• Theoretical Ecology: Principles and Applications

  1977influential reference

• Coupled SDE-ODE Modeling of Tumor-Immune Dynamics to Infer Biomarker Release

  2025cites this paper